ghk-cu injection safety human studies Wellness peptide craze: why people are injecting drugs 'not for consumption' How Much GHK-Cu Should You

Although relatively small in scale, First-in-Human trials generate several key insights that guide later clinical development.

2017;12(2):e0170728 63

On the other hand, for the L-NAME retrobulbar applicationinduced retinal ischemia model and BPC 157 therapy in rats, we should emphasize the point that animal studies per se may be cautious regarding their results, although the role of an animal model is indispensable (Vestergaard et al., 2019)

BPC-157 is unusually stable in human gastric juice for a peptide, which is why oral and capsule formats appear in research planning, especially for gut models

Capillary density increased in BPC-157-treated burns, confirming the angiogenic effects observed in other wound models